These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12729393)

  • 1. Analysis of survival data with missing measurements of a time-dependent binary covariate.
    Halabi S; Wun CC; Davis BR
    J Biopharm Stat; 2003 May; 13(2):253-70. PubMed ID: 12729393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint models for efficient estimation in proportional hazards regression models.
    Slasor P; Laird N
    Stat Med; 2003 Jul; 22(13):2137-48. PubMed ID: 12820279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case study of the effect of covariate adjustment in a sequential survival clinical trial.
    Todd S; Sahdra M
    J Biopharm Stat; 2001 Nov; 11(4):297-311. PubMed ID: 12018781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple test for independent censoring under the proportional hazards model.
    Lee SY; Wolfe RA
    Biometrics; 1998 Sep; 54(3):1176-82. PubMed ID: 9840972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of cumulative incidence function under the proportional hazards model.
    Cheng SC; Fine JP; Wei LJ
    Biometrics; 1998 Mar; 54(1):219-28. PubMed ID: 9544517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of treatment effect under non-proportional hazards and conditionally independent censoring.
    Boyd AP; Kittelson JM; Gillen DL
    Stat Med; 2012 Dec; 31(28):3504-15. PubMed ID: 22763957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference for the proportional hazards model with misclassified discrete-valued covariates.
    Zucker DM; Spiegelman D
    Biometrics; 2004 Jun; 60(2):324-34. PubMed ID: 15180657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of the quartiles of survival time and survival probability.
    Hemyari P
    J Biopharm Stat; 2000 Aug; 10(3):299-318. PubMed ID: 10959913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power calculation for a score test in the dependent censoring model.
    Lee SY
    Stat Med; 1996 May; 15(10):1049-58. PubMed ID: 8783441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model.
    Demissie S; LaValley MP; Horton NJ; Glynn RJ; Cupples LA
    Stat Med; 2003 Feb; 22(4):545-57. PubMed ID: 12590413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing time-by-covariate interactions in relative survival models using restrictive cubic spline functions.
    Bolard P; Quantin C; Abrahamowicz M; Esteve J; Giorgi R; Chadha-Boreham H; Binquet C; Faivre J
    J Cancer Epidemiol Prev; 2002; 7(3):113-22. PubMed ID: 12665210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trials for the real world: making as few and as reasonable assumptions as possible.
    Baker SG; Kramer BS
    Stat Methods Med Res; 2008 Jun; 17(3):243-52. PubMed ID: 17925312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival model predictive accuracy and ROC curves.
    Heagerty PJ; Zheng Y
    Biometrics; 2005 Mar; 61(1):92-105. PubMed ID: 15737082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.